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ABSTRACT
CarD is an essential and global transcriptional reg-
ulator in mycobacteria. While its biological role is
unclear, CarD functions by interacting directly with
RNA polymerase (RNAP) holoenzyme promoter com-
plexes. Here, using a fluorescent reporter of open
complex, we quantitate RPo formation in real time
and show that Mycobacterium tuberculosis CarD has
a dramatic effect on the energetics of RNAP bound
complexes on the M. tuberculosis rrnAP3 ribosomal
RNA promoter. The data reveal that Mycobacterium
bovis RNAP exhibits an unstable RPo that is stabi-
lized by CarD and suggest that CarD uses a two-
tiered, concentration-dependent mechanism by as-
sociating with open and closed complexes with dif-
ferent affinities. Specifically, the kinetics of open-
complex formation can be explained by a model
where, at saturating concentrations of CarD, the rate
of bubble collapse is slowed and the rate of opening
is accelerated. The kinetics and open-complex stabil-
ities of CarD mutants further clarify the roles played
by the key residues W85, K90 and R25 previously
shown to affect CarD-dependent gene regulation in
vivo. In contrast to M. bovis RNAP, Escherichia coli
RNAP efficiently forms RPo on rrnAP3, suggesting an
important difference between the polymerases them-
selves and highlighting how transcriptional machin-
ery can vary across bacterial genera.
INTRODUCTION
The regulation of gene expression via the control of DNA
transcription allows all living organisms to adapt their cel-
lular biochemistry to changes in their environment. In bac-
teria, the transcriptional machinery consists of RNA poly-
merase (RNAP) holoenzyme composed of the catalytic core
enzyme (′2) and a dissociable sigma factor () sub-
unit that directs promoter recognition. Transcription ini-
tiates when RNAP holoenzyme recognizes a promoter se-
quence and forms the RNAP-promoter closed complex
(RPc) where the DNA strands are still annealed in the
duplex. Through a series of conformational changes the
RNAP-promoter open complex (RPo) forms where the
DNA strands are melted from the −10 to +2 positions
and the active site is accessible to the initiating nucleotide.
In Escherichia coli, the mechanism of open-complex for-
mation includes multiple kinetic intermediates between the
initially bound complex and the stable open complex (1).
While the core machinery and major intermediate states
are conserved across bacteria, the detailed kinetics of tran-
scription likely vary between bacterial species to accommo-
date different physiologies and niches. Therefore, a minimal
kinetic scheme describing promoter binding and opening
by RNAP in two reversible steps (R + P ↔ RPc ↔ RPo)
provides a useful starting point when investigating open-
complex formation in a non-model system.
Regulation of transcription initiation is achieved through
the modulation of the stabilities of intermediate states
and/or the rates of exchange between these states on the
pathway to promoter escape. Transcription factors can me-
diate this regulation by directly affecting the polymerase-
promoter interaction, manipulating the equilibrium be-
tween RPc and RPo, or affecting rates of promoter escape
(2,3).Much of what has been studied in terms of the mecha-
nisms of transcription initiation and its regulation has used
E. coli as a model system. However, it has become evident
that some bacteria require specialized factors to allow for
efficient gene transcription. For example, many of the se-
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quences and proteins required to regulate transcription ini-
tiation in E. coli are absent in mycobacteria, including Fis
(4), DksA (5), AT-rich upstream activating elements (6,7)
and GC-rich discriminator sequences (8). The question re-
mains how bacteria missing these factors confer efficient
and regulable transcription.
CarD is a recently discoveredRNAP-binding protein that
is conserved in numerous bacterial species but not present in
E. coli. CarD homologs are essential inMycobacterium tu-
berculosis, Mycobacterium smegmatis (9) and Myxococcus
xanthus (10) and knockouts were not attainable in Borre-
lia burgdorferi (11). Furthermore, CarD is essential for the
response of M. tuberculosis to oxidative stress and certain
antibiotics, as well as the acute and persistent infection of
mice (9,12). Given the tremendous impact ofM. tuberculo-
sis on global health (1.3million related deaths a year,WHO,
2013), it is of particular interest to understand unique bio-
chemical pathways required by this pathogen. Yet, the rea-
sons for CarD essentiality remain enigmatic primarily due
to a lack of understanding of its molecular mechanisms.
CarD is associated with all RNAP-A (mycobacterial
house-keeping sigma, homologous to E. coli 70) transcrip-
tion initiation complexes within theM. smegmatis genome
(13) and interacts directly with the1 region of theRNAP
subunit through its N-terminal RNAP interaction domain
(RID) (9–10,12). The current model for CarD activity is
that this protein is directed to promoters via its interaction
with RNAP  (13,14). At the promoter, a basic patch in
the C-terminus of CarD contacts the DNA and the associ-
ation ofRNAP-boundCarDwith the promoterDNAstabi-
lizes the RNAP-promoter complex (13,14). Within this sta-
bilized CarD-RNAP-promoter complex, a conserved tryp-
tophan in CarD is required for proper transcriptional reg-
ulation, however its exact role is still unknown. Together,
these three activities of CarD (RNAP binding, DNA bind-
ing and the conserved tryptophan) promote a gene expres-
sion profile that supports viability (9,12,14), but the mech-
anism by which CarD regulates transcription is unknown.
Understanding howCarD stabilizes RNAP-promoter com-
plexes and regulates transcriptional activity is crucial for de-
veloping models of transcriptional regulation in mycobac-
teria and for furthering our knowledge of the molecular
physiology ofM. tuberculosis.
Here, we perform a detailed mechanistic analysis of M.
tuberculosis CarD in the context of open-complex forma-
tion using a real-time fluorescence assay on the rrnAP3 ribo-
somal RNApromoter fromM. tuberculosis. CarD is known
to regulate transcription from this promoter and is an acti-
vator of ribosomal RNA transcription (9). We show that
CarD has dramatic effects on both the equilibrium con-
centration of open complex and on the kinetics of the ap-
proach to equilibrium. Analysis of CarD concentration-
dependent data suggest that CarD stabilizes open complex
via a two-tiered kinetic mechanism. First, CarD associates
with RNAP open complexes with high affinity and slows
the rate of DNA closing. Second, CarD associates with
RNAP closed complexes with lower affinity and increases
the rate ofDNAopening. Thus, we propose thatCarD regu-
lates transcription by increasing the stability of RPo relative
to RPc by affecting both the effective forward and reverse
rates between these two states. Furthermore, comparisons
between open-complex formation by E. coli andMycobac-
terium bovis RNAPs suggest that E. coli does not posses
a homolog of CarD because its polymerase is intrinsically
more active in open-complex formation.
The work presented here reveals important details of the
mechanism of CarD-dependent transcription initiation in
mycobacteria and provides an example of the possible in-
trinsic differences between RNAPs from different classes
of bacteria. This observation highlights the importance of
research in prokaryotic transcription in organisms other
than E. coli, especially with respect to understanding mech-
anisms of transcriptional regulation in pathogenic species
such asM. tuberculosis. Lastly, our findings provide an im-




Mycobacterium bovis core RNAP and A were over-
expressed and purified using methods slightly modified
from the literature (15). Mycobacterium bovis RNAP
holoenzyme is identical toM. tuberculosisRNAP except for
the 69th residue of ′ which is a proline in M. bovis and
an arginine in M. tuberculosis. The M. bovis core RNAP
subunits were co-over-expressed from plasmid pAC22 in
BL21(DE3) pRARE2. Cells were grown at 37◦C until an
OD600 of 0.8. Cells were induced with 250 M Isopropyl -
D-1-thiogalactopyranoside (IPTG) and grown 4 h at 20◦C.
Cell pellets were lysed and loaded onto a 10mLNi2+ affinity
column (HP HiTrap, GE Healthcare) using a 5–1000 mM
imidazole gradient. The eluted sample was dialyzed, con-
centrated and further purified by size exclusion chromatog-
raphy (HiPrep Sephacryl 300, Pharmacia). The peak of core
RNAPwas dialyzed in storage buffer (50% glycerol, 10 mM
Tris pH 7.9, 200 mM NaCl, 0.1 mM ethylenediaminete-
traaceticacid (EDTA), 1 mM MgCl2, 20 M ZnCl, 2 mM
Dithiothreitol (DTT)), concentrated to 4 M (Vivaspin 20,
MWCO 100 kDa, GEHealthcare), flash frozen in liquid ni-
trogen and stored at −80◦C.
Mycobacterium bovis A was over-expressed from plas-
mid pAC27 BL21(DE3) pRARE2. Cells were grown at
37◦Cuntil an OD600 of 0.8. Cells were induced with 250M
IPTG and grown 4 h at 20◦C. Cell pellets were lysed and A
was purified by Ni2+ affinity chromatography (HP HiTrap,
Pharmacia) using a 5–1000 mM imidazole gradient. Eluted
protein was dialyzed into storage buffer (10 mM Tris pH
7.9, 250 mM NaCl, 0.1 mM EDTA, 1 mM MgCl2, 20 M
ZnCl, 2 mM DTT), concentrated to 24 M (Vivaspin 20,
MWCO 30 kDa, GE Healthcare), flash frozen and stored
at −80◦C.
Mycobacterium tuberculosis CarD was over-expressed
from a pETSUMO plasmid (13). Cells were grown at 37◦C
until OD600 of 0.8, induced with 1 mM IPTG, and grown
3 h at 37◦C. Cell pellets were lysed and His-SUMO-CarD
was purified by Ni2+ affinity chromatography (Ni-NTA
Agarose, Qiagen). Elution at 250mM imidazolewas quanti-
fied and His-Ulp1 protease added to cleave the His-SUMO
tag from CarD. This mix was dialyzed overnight in 3 l of 20
mM Tris pH 8.0, 150 mM NaCl and 1 mM -ME and di-
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was added to dialyzed proteins and, after incubating for 1 h
at 4◦C, CarD was collected in the flow through. Protein was
concentrated to 100 M (Vivaspin 20, MWCO 3 kDa, GE
Healthcare), flash frozen and stored at −80◦C.
Preparation of fluorescent promoter DNA fragments
The DNA template contained the −41 to +4 bases of the
rrnAP3 ribosomal RNA promoter (16) of M. tuberculo-
sis centered in a 150 bp template (Supplemental Infor-
mation). Fluorescently labeled promoter DNA was pre-
pared as previously described (17). In short, two 85-mer
oligonucleotides with a 20 bp overlapping sequence were
synthesized and high performance liquid chromatogra-
phy (HPLC) purified (IDT). The 85-mer corresponding to
the non-template strand was ordered with a C6 amine-
modification on the +2 thymine for covalent attachment to
Cy3-NHS (Lumiprobe). Labeled oligonucleotides were pu-
rified from unlabeled oligos and excess Cy3 using reverse-
phase chromatography (C18 column, XTerra). Template
and Cy3-non-template strands were annealed and extended
with Taq polymerase (Invitrogen). The extension products
were then purified byHPLC (DNASwift Column,Dionex).
Finally, the pure Cy3-labeled extension products were spin-
concentrated and exchanged into Tris-EDTA buffer (Milli-
poreAmiconUltra,MWCO30kDa). Concentrations of ds-
DNA (A260) and Cy3 (A550) were measured by spectropho-
tometer (Nanodrop) and indicated a equimolar ratio of dye
to DNA template demonstrating 100% labeling. Labeled
DNA template was stored at −20◦C.
Stopped-flow assay for real-time monitoring of open-complex
formation
Stopped-flow experiments were performed as previously de-
scribed (17,18) with minimal exceptions. All experiments
were performed by mixing equal volumes of protein solu-
tion from one syringe with fluorescent promoter DNA from
the other syringe. Accordingly, initial syringe concentra-
tions of protein and DNA were prepared at twice the de-
sired final concentration for the reaction. Including contri-
butions from protein storage buffers, final reaction buffer
conditions were as follows: 14 mM Tris pH 8.0, 120 mM
NaCl, 10 mMMgCl2, 1 mMDTT, 0.1 mg/ml bovine serum
albumin (BSA) and 10% glycerol by volume.
Protein solutions for stopped-flow experiments were pre-
pared as follows. In the case ofMboRNAP, core was mixed
with saturating concentrations of A and allowed to equi-
librate for 15 min at room temperature. In the case of
EcoRNAP, 70-saturated holoenzyme was used (New Eng-
land Biolabs). When required, CarD was added to RNAP
holoenzyme and allowed to equilibrate for an additional 15
min at room temperature. Protein solutions were then di-
luted into a solution containing 10 mMTris pH 8.0, 40 mM
NaCl, 10 mM MgCl2, 1 mM DTT and 0.1 mg/ml BSA.
Since MboRNAP core storage buffer contained 50% glyc-
erol, the protein solution contained 10% glycerol by volume.
For all experiments, any absence of protein volume was bal-
anced by its appropriate storage buffer in order to preserve
identical buffer conditions for different reactions.
PromoterDNA solutions were prepared for stopped-flow
experiments as follows. Stock DNA was diluted to 20 nM
into buffer containing 10 mM Tris pH 8.0, 40 mM NaCl,
10 mMMgCl2, 1 mMDTT, 0.1 mg/ml BSA and 10% glyc-
erol by volume. Glycerol was added to the DNA solution to
match the glycerol content of the protein solution, to mini-
mize rapid mixing artifacts that can occur with asymmetric
viscosities between syringes.
Experiments were performed on an SX-20 stopped-flow
spectrophotometer (Applied Photophysics, dead-time < 2
ms) with a shot volume of 150 l, using excitation at 515
nm (monochromator), and emission at 570+ nm (long-pass
filter). Unless otherwise noted, data were collected for 20
min and at 25◦C by sampling 10,000 points in a logarithmic
decay over the time course of the experiment. A circulating
water bath with active feedback was used to maintain tem-
perature within 0.1◦C.Multiple buffer shots as well as DNA
only shots were performed before every experiment. At least
two shots were collected for every protein condition, which
were averaged before plotting as fold change (FC) where FC
= (F−F0)/F0, where F= experimental signal− buffer sig-
nal in volts and F0=DNA signal− buffer signal in volts. In
all figures, error bars of fold change represent the standard
error of the mean (SEM) for conditions that were repeated
multiple times on different days. From these SEMs, aver-
age errors were then applied to conditions that were only
repeated multiple times on the same day to better estimate
the real error for these points.
Triple exponential fits of kinetic traces to extract observed
rates
Fold changes as a function of time were fit to a sum of expo-
nentials using the ProData Viewer software (Applied Pho-
tophysics). Single and double exponentials were insufficient
to capture the entire shape of the curve without substantial
systematic residual error and triple exponential fits of the
entire time course yielded inconsistent assignment of phases
(fast, medium and slow fits were interchangeable between
a1, k1, a2, k2, a3 and k3). To fit the curves with three expo-
nentials while preserving assignment of fast, medium and
slow phases, 1–1200 s was fit to a double exponential and
the amplitudes and observed rates for the medium (a2, k2)
and slow (a3, k3) phases were fixed. Then, a third exponent
was added and the time for fitting was expanded to include
0.1–1200 s in order to capture the fastest phase (a1, k1). In
this manner, the curves could be fit with three exponentials
from 0.1 to 1200 s, and assignments of amplitudes and ob-
served rates for all phases between traces remained consis-
tent. In all figures, error bars of observed rates represent the
SEM for conditions that were repeated multiple times on
different days. From these SEMs, average errors were then
applied to conditions that were only repeatedmultiple times
on the same day to better estimate the real error for these
points.
Kinetic simulations
Simulation of the kinetic model of open-complex forma-
tion was carried out in MATLAB R2014b (Mathworks).
Model parameters were determined by manually adjusting
rate constants and comparing with the data. The model was
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observed rate as functions of RNAP and CarD concentra-
tions were best fit. By assuming that the apparent bimolec-
ular association rates were all equal, fixing the equilibrium
between closed and open complex based on theMboRNAP
data in the absence of CarD, and requiring that the model
satisfied detailed balance, only three adjustable rate con-
stants remained. This allowed for the manual exploration
of parameter space and yielded a model that is able to cap-
ture the observed trends. The rate constants used to gener-
ate Figure 6 are listed in the Supplemental Information.
RESULTS
A real-time fluorescence-based assay of open complex
To detect the formation of open complexes, a Cy3 label
was incorporated on the +2 nucleotide of the non-template
strand of a M. tuberculosis rRNA promoter rrnAP3 DNA
template via a NHS-C6 amide linkage (Figure 1A). Cy3 ex-
hibits a 2-fold enhancement in fluorescence intensity in the
open complex and has been used to monitor DNA opening
and promoter escape inE. coli (17). The rrnAP3 promoter is
themajor ribosomal RNApromoter inM. tuberculosis (16),
has been used previously in studies of CarD, and is thought
to be regulated by CarD in vivo (13,14). Mixing of protein
components with labeled DNA templates was performed
via stopped-flow spectrophotometry and fluorescence was
monitored for 20 min. The addition of 21 nME. coliRNAP
(EcoRNAP) sigma factor 70 (70) holoenzyme to rrnAP3
resulted in robust enhancement of the fluorescence inten-
sity as compared to DNA alone (>60% increase or an
enhancement of 0.6, Figure 1B). In contrast, very small
(∼0.05) fluorescence enhancements are observed when the
same concentration of EcoRNAP is added to templates
lacking the rrnAP3 promoter sequence (Figure 1B), demon-
strating that fluorescence enhancement is promoter depen-
dent. Furthermore, an enhancement of approximately 0.3
is observed at low temperature where open-complex for-
mation is inhibited (19–21) and the fluorescence enhance-
ment increases with increasing temperature consistent with
the known temperature-dependence of open-complex for-
mation (Figure 1C). A possible structural rational for the
specific dependence on open complex exhibited by the ob-
served fluorescence enhancement is that the +2 position is
positioned downstream of closed complex DNase I foot-
prints, but is located within the footprint of open complex
(22). Taken together, these control experiments confirm that
fluorescence enhancement of a non-template +2 Cy3 in the
M. tuberculosis rrnAP3 template DNA faithfully tracks the
formation of the open initiation complex. Importantly, as
with EcoRNAP, M. bovis RNAP (MboRNAP, identical to
M. tuberculosisRNAP except ′ R69 is P69) also stimulates
fluorescence enhancement in a promoter- and temperature-
dependent manner (Figure 1D and E). The time traces ob-
tained in this assay exhibit multiple phases consistent with
the known kinetic complexity of transcription initiation (1)
and provide insight into both the kinetics of open-complex
formation and the equilibrium concentration of open com-
plex.
M. bovis RNAP forms open complex less efficiently than E.
coli RNAP on rrnAP3
We first studied the concentration dependence of
EcoRNAP (70) and MboRNAP (A) holoenzymes
on open-complex formation on theM. tuberculosis rrnAP3
promoter at 25◦C. Fluorescence enhancements after the
addition of 2–283 nM EcoRNAP (Figure 2A) or 37.5–600
nM MboRNAP (Figure 2B) were monitored for 20 min.
Final fold enhancements were plotted versus RNAP
holoenzyme concentration and fit to extract a concen-
tration at which the enhancement is half-maximal (Keff,
Figure 2C). As expected, the amount of open complex
increases as concentration increases for both forms of
RNAP, however EcoRNAP exhibits a Keff almost 10-fold
smaller thanMboRNAP (23 ± 5 nM versus 212 ± 43 nM,
95% confidence bounds). More strikingly, at saturating
concentrations of the respective polymerases, the fluo-
rescence enhancement for EcoRNAP is 1.44 ± 0.1 while
MboRNAP only reaches an enhancement of 0.30 ± 0.1.
The enhancement for EcoRNAP is comparable to that
described previously for EcoRNAP on a consensus pro-
moter (∼1.4) (17), suggesting that this signal is indicative of
fully open DNA (i.e. 100% open complex) on rrnAP3. By
comparison, MboRNAP A holoenzyme, even when fully
occupying the DNA template at saturating concentrations
of polymerase, is not capable of opening a large percentage
of the promoters leaving the majority of bound complexes
in the closed state. This demonstrates that MboRNAP
forms a significantly less stable open complex as compared
to EcoRNAP, even on its own mycobacterial promoter.
CarD stabilizes the open complex ofMboRNAP
We next looked at the effect of CarD on open-complex
formation. Holoenzyme was incubated with CarD for 15
min prior to mixing with the DNA template and record-
ing changes in fluorescence intensity over time. While CarD
shows no fluorescence enhancement when added to DNA
alone and has little effect on the fluorescence signal from
EcoRNAP (Supplementary Figure S1), its presence leads
to a dramatic increase in the magnitude of fluorescence
enhancements observed when incubated with MboRNAP
(Figure 3A). As fluorescence enhancement serves as a re-
porter of open complex, we conclude that CarD signifi-
cantly stabilizes open complex specifically for MboRNAP.
This is consistent with known differences in the 1 lobe of
EcoRNAP andMboRNAP on the CarD-binding interface
that would predict tighter binding ofM. tuberculosis CarD
to MboRNAP than to EcoRNAP (23). In the presence of
225 nM MboRNAP, a rise in fluorescence fold change can
be seen as the concentration of CarD is increased from 0
- 1.1 M. The concentration of CarD that exhibits half-
maximal effect (77 ± 35 nM) and the fold fluorescence en-
hancement over 0 M CarD at saturation (6.2-fold) was
determined by normalizing the equilibrium (final) fluores-
cence enhancements relative to 0 M CarD and fitting to
a binding isotherm (Figure 3B). Assuming that EcoRNAP
generates 100% open complex at saturating concentrations
(283 nM, Figure 2A) and that MboRNAP generates the
same enhancement of signal per open complex, at saturat-
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Figure 1. A real-time fluorescence assay for monitoring open-complex formation. (A) The assay utilizes a Cy3 dye at the +2 position of the non-template
strand of a rrnAP3 ribosomal RNA promoter DNA template. The Cy3 has a baseline fluorescence in the free and closed complexes that is enhanced upon
the formation of open complex. (B) EcoRNAP-dependent (21 nM) fluorescence enhancement in the presence (green) and absence (red) promoter sequence
at 25◦C. (C) EcoRNAP-dependent (21 nM) fluorescence enhancement at 10◦C (blue), 25◦C (green) and 37◦C (red). (D)MboRNAP-dependent (100 nM)
fluorescence enhancement in the presence (green) and absence (red) of promoter sequence at 25◦C. (E) MboRNAP-dependent (100 nM) fluorescence
enhancement at 10◦C (blue), 25◦C (green) and 37◦C (red).
that are in open complexes at equilibrium in the presence of
225 nM MboRNAP increases from approximately 15% to
93% (Figure 3A).
To compare the MboRNAP holoenzyme concentration
dependence in the presence and absence of CarD, a holoen-
zyme titration (37.5–600 nM)was performed in the presence
of saturating CarD (1 M) at 25◦C (Figure 4A). Compar-
ing RNAP titrations in the presence and absence of CarD
shows that 1 M CarD reduces Keff from 212 ± 43 nM to
106± 3 nM and increases the amount of open complex 4.3-
fold at saturation (Figure 4B).
The ability of CarD to stabilize open complexes is
also temperature dependent. In experiments with 100 nM
MboRNAP in the presence and absence of 1 M CarD,
traces at different temperatures show different amounts of
CarD-dependent fold change (Figure 4C). Specifically, the
CarD effect is significantly larger at 25◦C (4.2-fold) than
it is at either 10◦C (1.5-fold) or 37◦C (1.9-fold). These ob-
servations fit well with the known temperature-dependence
of open complex (19–21). At low temperature, opening is
severely inhibited and the binding energy from CarD is not
sufficient to tilt the landscape enough toward opening to
have a large effect. At 25◦C, the energy landscape is more
balanced between closed and open and the extra binding
energy supplied by CarD is able to significantly affect the
equilibria between the two states. Lastly, at 37◦C, open com-
plex formsmore readily than at lower temperatures and thus
there is an appreciable amount of open complex to begin
with (i.e. 50%). In this case, even if CarD is capable of stabi-
lizing all bound complexes in the open form, it will exhibit a
lower fold change in open complex equilibrium concentra-
tion (i.e. 2-fold).
CarD pushes the equilibria of polymerase-bound states to-
ward open complex
In the presence of a saturating concentration ofMboRNAP
(450 nM) where the DNA templates are fully occupied by
holoenzyme, the amount of open complex observed in the
presence of CarD is dramatically increased in the presence
of 1 M CarD (Figures 2B and 4A). This can only be the
case if CarD stabilizes the open complex relative to closed
complex either by increasing the effective rate of opening or
decreasing the effective rate of closing or both.
Furthermore, the observation that CarD stabilizes open
complexes relative to closed complexes suggests that CarD
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Figure 2. RNAP concentration dependence of promoter opening. (A) Flu-
orescence enhancement as a function of time for increasing concentrations
of EcoRNAP (0–238 nM). (B) Fluorescence enhancement as a function of
time for increasing concentrations of MboRNAP (0–600 nM). (C) Equi-
librium fluorescence fold change for both EcoRNAP andMboRNAP as a
function of polymerase concentration. Fits (solid lines) of the data allow
the extraction of concentrations of half-maximal effect (23 ± 5 nM and
212 ± 43 nM) and saturated fluorescence enhancements (1.44 and 0.28)
for EcoRNAP andMboRNAP, respectively.
complex. In a thermodynamic cycle (Figure 4D) where
binding of CarD is coupled to the open/closed equilibrium,
the sum of free energies around the cycle must be zero. The
data show thatRPo ismore stable relative toRPc in the pres-
ence of CarD (G4 < G1). Since the sum of free energies
along paths that begin and end in the same state must be the
same,G1 +G2 = G3 +G4. This then requires the free
energy differences between RP and RP·CarD in the open
and closed states to satisfy G2 < G3. Thus, as the free
energy difference determines the affinity (Kd = e−G/RT), we
predict that CarD binds more tightly to open complex than
to closed complex.
The kinetics of open-complex formation can be monitored via
the slowest observed rate
The time-dependent traces allow for an analysis of the ki-
netics of open-complex formation. The traces are well fit by
a triple exponential resulting in three observed rates, con-
sistent with the well-known multi-state kinetic complexity
of open-complex formation (1) (Figure 5A, Materials and
Methods). The three observed rates differ by orders of mag-
nitude with a fast (k1obs ∼ 1 s−1), intermediate (k2obs ∼ 0.1
s−1) and slow (k3obs ∼ 0.005 s−1) observed rates. In traces ex-
hibiting robust opening (i.e. high polymerase or high CarD
concentrations), the amplitude of the curve is dominated
by the amplitude of the slowest observed rate (Supplemen-
tary Figure S2). Furthermore, although promoter-less con-
trol traces (Figure 1B and D) do exhibit a modest amount
of fluorescence enhancement, this enhancement occurs very
rapidly (< 1 s) and the slow phase (k3obs) is not observed.
Therefore, we reason that, to a first-approximation, the
fastest observed rates report on a protein–DNA interaction
not related to opening (i.e. binding) and the slowest ob-
served rate (k3obs) specifically reports on the approach to
equilibration of open complex forMboRNAP.
Observed rates typically represent combinations of mi-
croscopic rate constants. In the simplest case, the two states
A and B are connected by a forward and a reverse rate con-
stant. In this case, if one starts with the system entirely in
A and monitors the approach to equilibrium, the observed
rate will simply be the sum of the two rate constants. There
are two mechanisms by which B could be stabilized relative
to A: (i) the forward rate constant could be accelerated or
(ii) the reverse rate constant could be slowed. In the first
case, B would be stabilized and the observed rate would in-
crease while in the second case, B would be stabilized and
the observed rate would decrease. In more complicated ki-
netic mechanisms, the interpretationmay not be so straight-
forward, but nonetheless, these two limiting cases serve as
a useful backdrop for extracting mechanistic information
from trends in an observed rate (Supplementary Figure S3).
CarD exhibits a concentration-dependent effect on the kinet-
ics of open-complex formation
To extract information regarding the effect of CarD on the
kinetics of open-complex formation, we first analyzed the
CarD-dependence of k3obs using data collected at 150 nM
MboRNAP (Figure 5B). Here, k3obs decreases with increas-
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Figure 3. CarD increases open-complex formation with MboRNAP. (A) Fluorescence enhancement as a function of time for 225 nM MboRNAP with
increasing concentrations of CarD (0–5.55 M) at 25◦C. (B) Equilibrium values of fluorescence enhancement are plotted as a function of CarD concentra-
tion. A fit (solid line) of the data reveals a concentration of half-maximal effect Keff = 77 ± 35 nM and an amplitude of 6.2-fold over 225 nMMboRNAP
alone.
Figure 4. MboRNAP titration at saturating CarD. (A) Fluorescence enhancement as a function of time for 1 M CarD with increasing concentrations
ofMboRNAP (0–450 nM) at 25◦C. (B) Equilibrium values of fluorescence enhancement fold change are plotted in the presence (red) and absence (green)
of 1 MCarD. The data were best fit with an amplitudes of 1.3 and 0.28 and Keff of 106 ± 3 nM and 212 ± 43 nM in the presence and absence of CarD,
respectively. (C) Observed traces for 100 nMMboRNAP in the presence or absence of 1 M CarD at 10◦C (blue), 25◦C (green) and 37◦C (red). The bar
graph shows the fold increase in equilibrium fluorescence enhancement for each temperature. (D) The thermodynamic cycle linking closed complex (RPc),
open complex (RPo), closed complex bound to CarD (RPcCarD) and open complex bound to CarD (RPoCarD). The equality shown below follows since
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Figure 5. Kinetics of open-complex formation. (A) Triple exponential fits
are required to obtain fits with good residuals for traces where DNA open-
ing is occurring. A typical trace, the fits, and the resulting residuals are
shown forwith double (red) and triple exponential (blue) fits. (B) TheCarD
concentration dependence of k3obs in the presence of 150 nM (black) or
225 nM (red)MboRNAP. (C) TheMboRNAP concentration dependence
of k3obs in the presence (black) and absence (red) of 1 MCarD.
verse rate in order to stabilize open complex. This interpre-
tation is consistent with recent results showing that CarD
increases the lifetime of open complexes in the presence of
competitor DNA (14) and suggests that CarD functions by
inhibiting bubble collapse.
Interestingly, when the above analysis is repeated with
a higher concentration of MboRNAP (225 nM), k3obs ex-
hibits a markedly different dependence on the concentra-
tion of CarD (Figure 5B). At low concentrations of CarD
(0–100 nM), k3obs decreases with increasing concentration
as observed with 150 nM MboRNAP. However, at con-
centrations higher than 100 nM CarD, k3obs accelerates as
a function of CarD concentration and almost reaches the
magnitude observed in the absence of CarD. This biphasic
dependence of the observed rate suggests that CarD stabi-
lizes open complex via a more complicated mechanism and
points tomodels where CarDmodulates more than one rate
constant in the kinetic mechanism. It further suggests that
it does so with different concentration dependencies. There-
fore, we propose a model, discussed in detail below, where
CarD slows bubble collapse in the open complex at low con-
centrations and can also associate with closed complex at
high concentrations and accelerate DNA opening. Impor-
tantly, CarD is one of the highest expressed proteins inM.
tuberculosis (24) and quantitative western analysis shows
that the concentrations of CarD in the cell are similar to the
concentrations used for these assays (Supplementary Figure
S4) suggesting that CarD both accelerates DNA opening
and inhibits bubble collapse in vivo.
Since k3obs depends on RNAP concentration at 1 M
CarD (Figure 3), we analyzed this dependence further by
titratingMboRNAP concentration in the presence of 1 M
CarD. At this concentration of CarD, k3obs increases as a
function of polymerase concentration (Figure 5C). As in-
creasing RNAP concentration increases the rate at which
bound complexes will form, this result suggests that the rate
of CarD-stimulated open-complex formation also depends
on the rate of polymerase binding to the DNA template.
Importantly, in the absence of CarD, k3obs does not show
this dependency. Consistent with the rate limiting steps of
CarD-independent bubble formation taking place between
two bound complexes, k3obs is independent of MboRNAP
in this concentration range in the absence of CarD (Fig-
ure 5C). These observations provide further constraints to
models of the kinetic mechanism of CarD-dependent regu-
lation of open-complex formation.
A kinetic model with CarD binding to both open and closed
complexes
To understand the concentration-dependent effects of
CarD, a kinetic model of open-complex formation in the
presence of CarD was constructed (Figure 6A). The model
consists of five states including unbound DNA (R + P),
closed complex (RPc), open complex (RPo), CarD-bound
closed complex (RPcCarD) and CarD-bound open com-
plex (RPoCarD). In principle, CarDmay interact both with
DNA alone and unbound RNAP. However, CarD has been
found by ChIP-seq only in genomic positions where RNAP
holoenzyme is also found (13). In addition, the interaction
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Figure 6. A CarD-dependent kinetic model of open-complex formation.
(A) The model consists of five states: unbound DNA (R + P), closed
complex (RPc), open complex (RPo), closed complex bound to CarD
(RPcCarD) and open complex bound to CarD (RPoCarD). Values indi-
cate the ratio of rate constants between each pair of states in the model.
For example, at 250 nM, the forward and reverse rates between R + P and
RPc are equal. Furthermore, the ratio of forward to reverse rates between
RPc and RPo are 0.125 and 40 in the absence and presence of CarD, re-
spectively. The rates used to generate the figures below can be found in
Supplementary Information. (B) Simulations of the kinetic model titrating
CarD concentration with 150 nM (black) and 225 nM (red) MboRNAP.
(C) Simulations of the kinetic model titrating RNAP concentration with 0
nM (black) and 1 M (red) CarD.
the association of CarD to DNA-bound RNAP complexes
where itmay interact with both polymerase andDNAcoop-
eratively. For these reasons, CarD-DNA and CarD-RNAP
states are left out of the current model.
Initially models where CarD only associated with open
complex were attempted, but these models are unable to
capture the biphasic dependence of k3obs on CarD concen-
tration. However, a model where CarD also interacts with
closed complex is able to account for the concentration de-
pendencies of both the polymerase and CarD with a sin-
gle set of rate constants (Figure 6, Supplemental Methods).
Themodel has three key features: (i) CarD has a lower affin-
ity to closed complex than it does to open complex; (ii) in
the open complex, CarD inhibits the rate of bubble col-
lapse; and (3) in the closed complex, CarD accelerates the
rate of DNA opening. Importantly, the model was required
to satisfy detailed balance so that the energetics linking the
affinities of CarD to the equilibria between open and closed
complexes do not violate thermodynamics (Supplemental
Methods).
The model was used to simulate time-dependent traces of
open-complex formation and the resulting curves were fit
to extract an observed rate of the approach to equilibrium
(kobs). The model captures the dependence of the observed
rate on CarD concentration at different fixed MboRNAP
concentration (Figures 5B and 6B). Specifically, the ob-
served rate decreases initially at both polymerase concen-
trations and then increases more at 225 nM RNAP than it
does 150 nM RNAP. The model also captures the depen-
dences of the observed rate on RNAP concentration in the
presence and absence of 1 M CarD (Figures 5C and 6C).
Specifically, at 1 MCarD, the observed rate increases with
increasing RNAP concentration whereas in the absence of
CarD, the observed rate is RNAP-concentration indepen-
dent.
Lastly, the identical model parameters also reproduce the
trends in the equilibrium concentration of open complex as
a function ofMboRNAP andCarD (Supplementary Figure
S5). Although themodel does not explicitly include aCarD-
dependent change in the rates connecting free polymerase to
closed complex, the approximately 2-fold reduction in Keff
in the presence of 1 M CarD (Figure 4B) is captured by
the model (Supplementary Figure S5). This illustrates that
a lowerKeff is not necessarily due to a change in the energet-
ics of free polymerase relative to the closed complex. Since
open complexes cannot dissociate from the DNA without
closing first, any stabilization of open complex relative to
closed results in an increased apparent affinity of the poly-
merase for DNA.
CarD mutants are deficient in open-complex stabilization
Single amino acid mutants of CarD have previously been
used in vivo and in vitro to understand the roles played
by different domains or regions of the protein (12,14).
Three groups of mutants have been identified according to
their distinct phenotypic effects in vivo, namely those with
DNA-binding defects, RNAP interaction defects and with
an alanine substituted for a conserved tryptophan residue
(W85A). Although W85 is part of the DNA-binding do-
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lization of open complex, perhaps by interacting with the
upstream end of the DNA bubble (13,14).
CarD mutants that weaken the interaction with RNAP
(R25E, (12)), weaken the interaction with DNA (K90A,
(14)) andW85A (13,14) were used as representativemutants
from the three classes and were tested in the open-complex
formation assay. Fluorescence enhancement traces using
MboRNAP in the presence of 1MCarD (Figure 7A) show
that all three mutants are partially deficient in stabilizing
open complex relative to WT, as evidenced by their lower
equilibrium (final) fluorescence enhancements. Increasing
the concentration of mutant CarDs showed more enhance-
ment, but the final enhancements at the highest protein lev-
els tested were still less than 50% that of wild type (WT)
(Figure 7B, Supplementary Figure S6). Fits of the mutant
CarD titrations result in estimates of open-complex stabi-
lization and concentrations of half-maximal effect. K90A
and W85A both reach a maximum of 3-fold fluorescence
enhancement as opposed to the 6.2-fold enhancement seen
with WT CarD. The half-maximal concentrations of K90A
andW85A are 400± 48 nM and 381± 118 nM respectively
as compared to the 77 ± 35 nM observed with WT CarD.
The data for R25Ewere unable to be fit as we were unable to
reach saturation due to limitations of protein concentration,
but the activity of the RNAP-interacting domain mutant is
even further decreased relative to the other mutants. Taken
together, the data demonstrate that all three residues, and
by extension all three activities (polymerase binding, DNA
binding andW85 activity), are required for full CarD activ-
ity.
Fits of the time-dependent fluorescence enhancements
again showed three phases and the slowest rate (k3obs) in
the presence of CarD mutants depended on CarD concen-
tration as with WT CarD (Figure 7C, Supplementary Fig-
ure S6). However, the degree to which k3obs was decreased
was less in all the mutants compared to WT. Based on the
model that the decrease in k3obs is due to CarD’s ability to
inhibit DNA closing, this suggests that the mutants are un-
able to prevent bubble collapse to the same extent as WT.
More specifically, the initial decrease of k3obs observed as a
function of CarD concentration showed a similar concen-
tration dependence as WT for the W85A and K90A mu-
tants, but the observed rate decreased less (Figure 7C). In
contrast, R25E exhibited a much slower decrease suggest-
ing a lower affinity to open complex (Figure 7C) consistent
with previous work showing that this mutant associates less
strongly with MboRNAP (12). At higher concentrations,
W85A and K90A show signs of an increasing k3obs sug-
gesting that they are able to interact with closed complex
to accelerate DNA opening, but not to the same extent of
WT. Even though the observed rate does not decrease as
much as with WT CarD at low concentrations, it is not as
fast at higher CarD concentrations either (i.e. at 1 – 2 M
CarD). In contrast, R25E shows no signs of the increasing
phase of k3obs suggesting, perhaps, that it is unable to effec-
tively interact with closed complex at these concentrations.
These observations coupled with the reduced fluorescence
enhancement observed at saturating levels of mutant CarD,
suggest that W85A and K90Amutants are able to associate
with both open and closed complexes as in WT, but are de-
ficient in both inhibiting the rate of bubble collapse and in-
Figure 7. Mutants of CarD diminish the degree of open-complex stabi-
lization. (A) Fluorescence enhancement as a function of time are shown
for 225 nMRNAP + 1 MWT andmutant CarDs at 25◦C.W85A (green)
and K90A (red) traces generate less than half the open complex at equilib-
rium as compared toWT (blue) andR25E (purple) is even further compro-
mised. (B) Equilibrium fluorescence enhancement as a function of CarD
concentration taken from titrations of mutant CarDs (Supplementary Fig-
ure S6). (C) The CarD concentration dependence of k3obs for WT (blue),
W85A (green), K90A (red) and R25E (purple) mutant proteins.
creasing rate of opening. In contrast, it appears that the as-
sociation of R25E with the complexes occurs with a much
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DISCUSSION
A better understanding of the role ofM. tuberculosis CarD
in transcription initiation will not only be relevant to my-
cobacteria, but also to the diverse bacterial species that en-
code CarD homologs (9,13). The result that MboRNAP is
less able to form rrnAP3 open complexes as compared to
EcoRNAP rationalizes the essentiality of CarD in M. tu-
berculosis (and its absence from E. coli) and suggests that
polymerases from organisms in which CarD is found may
also be deficient in open-complex formation. This observa-
tion also stresses the importance of directly studying tran-
scription systems in a wide spectrum of bacteria, especially
in pathogens likeM. tuberculosis, that may diverge from tra-
ditional model systems.
Previous studies of the effect of CarD on transcription
initiation focused on open complex lifetimes in the pres-
ence of competitor DNA (13–14,25). Specifically, proteins
and DNA were allowed to come to equilibration and open-
complex stability was assayed by the time-dependent de-
cay of reporters of open complex (i.e. the production of
transcripts upon the addition of nucleoside triphosphate
(NTPs)). These valuable assays have led to the model where
CarD stabilizes open complex. However, in the cell, there is
no initial equilibration time and transcriptional regulation
must be enacted in real time. That is to say, the flux of tran-
script production must be attenuated or augmented. There-
fore, both the rate at which open complexes are formed and
the rate at which they decay are crucial for gene regulation
in vivo. With this mindset, the rates at which DNA opens
and closes in DNA-bound holoenzyme complexes and their
dependence on CarD likely have important regulatory con-
sequences.
In this study, we adapt a real-time, fluorescence-based as-
say to gain insights on the mechanisms used byM. tubercu-
losis CarD to stabilize mycobacterial open complexes. We
show that CarD stabilizes RPo forMboRNAP on rrnAP3 in
a concentration-dependent manner that saturates at 1 M
and approaches the level of stability displayed byEcoRNAP
on the same promoter. The fact that CarD increases the
concentration of open complex on RNAP-saturated DNA
templates demonstrates that CarD specifically affects the
equilibrium between promoter-bound complexes and sta-
bilizes RPo with respect to RPc. This result, in combination
with a thermodynamic cycle couplingCarDbinding and the
equilibrium between RPo and RPc, shows that CarD has a
higher affinity to open complex as compared to closed com-
plex. The temperature dependence of CarD activity also
matches well with the known temperature dependence of
open complex (Figure 4C) (19–21). Furthermore, the ki-
netics of the approach to equilibrium display interesting
trends as a function of both RNAP and CarD concentra-
tions. Specifically, the biphasic behavior of the slowest ob-
served rate (k3obs) as a function of CarD concentration at
high RNAP concentrations suggests that CarD uses more
than one mechanism to stabilize open complex (Figure 5B).
Lastly, we have constructed a detailed kinetic model of the
formation of open complex in the presence of CarD that
captures all of the experimental trends in the slowest ob-
served rate with a single set of parameters.
Importantly, k3obs also depends on RNAP concentration
at high concentrations of CarD (Figure 5C). Since the con-
centration of the polymerase affects the rate at which it en-
counters and binds the template, this suggests that the ef-
fect of CarD on the kinetics of open-complex formation
depends on the rate of association of RNAP. One possi-
bility is that CarD interacts with free polymerase and ac-
celerates its association with DNA. However, while we do
not exclude this interaction as part of CarD’s overall mech-
anism, it is unlikely to play a major role as k3obs shows no
RNAP concentration dependence in the absence of CarD
(Figure 5C, black) suggesting that only increasing the rate
of association of holoenzyme has no effect. Instead, to ac-
count for the above observations, we hypothesize that CarD
is able to associate with closed complex (Figure 6A). The
addition of this state to the mechanism has the potential to
account for all the data as the formation of a CarD-bound
closed complex will naturally depend on the concentrations
of both RNAP and CarD.
The full model postulates that at low concentrations,
CarD associates with pre-formed open complex and stabi-
lizes it, thus inhibiting its isomerization to closed complex.
At higher concentrations, CarD associates with closed com-
plex as well and destabilizes it, thus promoting its isomer-
ization to open complex (Figures 6 and 8). The model sat-
isfies detailed balance and is also consistent with the ob-
servation that CarD must have a higher affinity to RPo as
compared to RPc. We caution that we do not interpret the
presented model parameters as measurements of affinities
or equilibria. These parameters will need to be determined
via future experiments, however the ability of the model to
capture all the trends we observe with a single parameter
set suggests that the model topology is correct and is able to
capture the critical interactions betweenMboRNAP, CarD
andDNA.At saturating concentrations of bothRNAP and
CarD, the model predicts that CarD interacts with both
open and closed complexes and tilts the equilibrium toward
open complexes. As both proteins are present in high con-
centrations in the cell (> 1 M, Supplemental Methods,
Supplementary Figure S4 and (24)), both activities of CarD
are apt to play important roles in transcriptional regulation
in vivo.
Recently, DNA footprinting and transcription assays
were used to measure the effect of CarD on the stability of
the open complex and transcript production (25). This work
nicely shows that althoughmycobacterial RNAPmakes the
same contacts with the promoter as E. coli RNAP, it forms
an unstable open complex on the rrnAP3 promoter. Fur-
thermore, the addition of CarD at high concentrations led
to the stabilization of the open complex and stimulated sin-
gle rounds of transcript production. Our results are con-
sistent with these data with regard to CarD’s ability to in-
hibit bubble collapse in the open complex. Additionally, the
concentration-dependent kinetic analysis of the formation
of open complex significantly expands our understanding
of the mechanism of CarD and shows that it also functions
by accelerating bubble formation.
The two-step binding and opening model is able to cap-
ture all of the trends in observed rates presented in this
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Figure 8. Energy diagram. Schematic energy diagrams showing the relative free energies of closed (RPc) and open (RPo) complexes. In the proposedmodel,
in the absence of CarD (0 nM), RPc is more stable than RPo. In the presence of low concentrations (100 nM), CarD binds to and stabilizes RPo, effectively
increasing the energy barrier for closing and inhibiting bubble collapse. In the presence of high concentrations (1 M), CarD additionally interacts with
and destabilizes RPc, effectively decreasing the energy barrier for opening and accelerating the formation of RPo.
ing open-complex formation of E. coli RNAP on a range
of promoters (18,26) and to analyze open-complex forma-
tion for mycobacterial RNAP in the absence of transcrip-
tion factors (27). Given that the mechanism of initiation in
E. coli is known to be significantly more complex (1), we ex-
pect that the two-stepmodel will serve as a starting point for
more detailed studies of CarD’s kinetic mechanism of reg-
ulating transcription initiation in mycobacteria. Promoter-
specific initiation inE. coli involves transitions throughmul-
tiple closed and open complexes of varying stabilities which
are defined by conformational changes in both the DNA
as well as RNAP (1). One subtle possibility with respect to
the interpretation of the data presented is that early open
intermediates in the E. coli mechanism (i.e. I2) also exist in
the M. bovis mechanism and do not generate fluorescence
enhancement. In this case, the data could be explained via
the CarD-dependent acceleration of the formation of RPo
via its association with these intermediates instead of with
RPc. However, as transitions between intermediates prior
to melting of the transcription bubble are thought to be rate
limiting, transcription factors which act on these intermedi-
ates (i.e. CRP (28) and DksA (29)) can have more dramatic
effects on open-complex kinetics. Thus, while we favor the
model presentedwhereCarD interacts directly withRPc, we
exclude neither the possibility that multiple closed and open
intermediate states exist in the mechanism of mycobacterial
open-complex formation, nor the possibility that CarDmay
act on more than one of these states.
To dissect the roles played by different domains of CarD
within the context of the proposed kinetic mechanism, real-
time fluorescence enhancements were acquired using point-
mutants of CarD.Mutants of CarD that weaken its interac-
tions with DNA or the polymerase, or lack the critical tryp-
tophanW85 all show defects in open-complex stabilization.
The equilibrium concentration of open complex and the rel-
ative changes of the slowest observed rate with the DNA-
binding (K90A) and W85A mutants are consistent with a
model where they are able to associate with RNAP-bound
complexes, but are unable to generate full stabilization (Fig-
ure 7B). This interpretation suggests that K90 andW85 are
more important for the activity of CarD once it has bound
than they are for the recruitment of CarD to the initiation
complex. Furthermore, the trends in the observed rates for
these mutants suggest that they are defective in both the
inhibition of bubble collapse and the acceleration of DNA
opening (Figure 7C).
In contrast, in the case of the R25E mutant, the CarD
concentration dependence of both open-complex stability
and observed rate show significant shifts to higher concen-
trations (Figure 7B and C). This result is consistent with
the RID domain playing a role in the overall recruitment of
CarD to RNAP-DNA complexes. Furthermore, the effect
of 1 M R25E CarD is similar to the effect of WT CarD
on EcoRNAP (Supplementary Figure S7). This corrobo-
rates previous immunoprecipitation data that M. tubercu-
losis CarD associates with E. coli RNAP with low affinity
(9), possibly due to the fact that EcoRNAP lacks glutamate
138 which is thought to form a salt bridge with R25 that is
critical for CarD binding to RNAP  (12,23). Lastly, at the
highest concentration of R25E, the observed rate is slower
than the other mutants, but the equilibrium stabilization of
open complex is less. Based on this result, we speculate that
the dramatically reduced affinity of R25E completely pre-
vents it from interacting with closed complex at the concen-
trations tested.
Structural modeling has positioned W85 in a position to
interact with the upstream edge of the DNA bubble present
in open complex (13). Given this location and its chem-
ical nature, predictions of its role have included promot-
ing formation of open complexes, in a way analogous to
the tryptophan residues in  factors (14,30), or stabilizing
the open complex by intercalating into the distorted back-
bone of the DNA at the upstream edge of the open complex
(13,14). The data presented here are consistent with amodel
in which W85 performs both of these roles. While it is not
clear what interactions would lead to a different affinity be-
tween open and closed complex in WT CarD, one possibil-
ity is the hypothesized steric clash between W85 and closed
complex DNA (13). This clash would result in non-optimal
binding between the C-terminal domain of CarD andDNA
and could lead to a destabilization of CarD-bound closed
complex. This destabilization would naturally lead to an in-
crease in all rates leading out of the CarD-bound closed
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explaining the decreased affinity of CarD to closed complex
and would also lead to an increase in the rate of isomeriza-
tion to open complex resulting in an acceleration of DNA
opening.
In conclusion, the kinetic model of CarD-dependent
open-complex stabilization proposed here might have im-
portant consequences in terms of the gene-specific effects
of CarD. While CarD is localized in vivo at every A-
dependent promoter (13), its role at each promoter is un-
clear. The ability of CarD to accelerate opening and in-
hibit bubble collapse will likely lead to complex dependen-
cies on both promoter sequence and the presence of ad-
ditional transcriptional regulators. More specifically, CarD
could either inhibit or promote transcription, depending on
the basal kinetics of a given promoter and the basal rates of
DNA opening, bubble collapse and promoter escape. Fu-
ture research along these lines will be required to elucidate
the role of CarD across the genome.
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